Key Market Indicator:
F&G: 25
25.065,70 NASDAQ · 47.321,00 DOW · 6.739,65 S&P · 4.091,18 Gold · 63,89 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© Globe Newswire
08.10.2025
ISIN: FR0000120578

Sanofi SA
SAN

LISTED

EURONEXT
Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors
News Preview
AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
ISIN: FR0000120578

Sanofi SA
SAN

LISTED

EURONEXT
Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors
News Preview
AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2025
ISIN: KYG1996C1006

CARsgen Therapeutics Holdings Limited
2171

LISTED

HKSE
CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology
News Preview
SHANGHAI, Oct. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of CT071 (an autologous CAR T-cell product targeting GPRC5D) for the treatment of relapsed/refractory multiple myeloma (R/...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ACCESSWIRE
08.10.2025
ISIN: GB0034330679

Angle plc
AGL

LISTED

AIMX
Angle PLC Announces Strategy Update
News Preview
Appointment of Executive Chairman, proposed change of name and strategy updateCompany to pursue revised strategy and name change to CelLBxHealth plcDr. Jan Groen, the current Non-Executive Chairman and recognised oncology diagnostic industry veteran, to lead company as Executive ChairmanRevised strategy to sharpen focus on the provision of industry...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
08.10.2025
ISIN: US29664W1053

Esperion Therapeutics Inc
ESPR

LISTED

NASDAQ
Esperion Announces Pricing of Public Offering of Common Stock
News Preview
ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C), today announc...
Themefolio
Profiler
Peergroup
© BusinessWire
08.10.2025
ISIN: US69608A1088

Palantir Technologies, Inc.
PLTR

LISTED

NASDAQ
Securities Fraud Investigation Into Palantir Technologies Inc. (PLTR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Palantir Technologies Inc. (“Palantir” or the “Company”) (NASDAQ: PLTR) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PALANTIR TECHNOLOGIES INC. (PLTR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: CA09076M2004

BioVaxys Technology Corp.
BIOV

LISTED

CSE
BIOVAXYS ANNOUNCES LIFE OFFERING
News Preview
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it is undertaking a...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: CA09076M2004

BioVaxys Technology Corp.
BIOV

LISTED

CSE
BIOVAXYS ANNOUNCES LIFE OFFERING
News Preview
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Oct. 7, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it is undertaking a non-bro...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US4718711033

Jasper Therapeutics, Inc.
JSPR

LISTED

NASDAQ
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NAS...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US5926881054

Mettler-Toledo International Inc
MTD

LISTED

NYSE
Mettler-Toledo International Inc. to Host Third Quarter 2025 Earnings Conference Call
News Preview
Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its third quarter 2025 financial results after the market close on Thursday, November 6, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Pres...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: KY61559X1045

MoonLake Immunotherapeutics
MLTX

LISTED

NASDAQ
Rosen Law Firm Encourages MoonLake Immunotherapeutics Investors to Inquire About Securities Class Action Investigation - MLTX
News Preview
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US29261A1007

Encompass Health Corp
EHC

LISTED

NYSE
Encompass Health announces date of 2025 third quarter earnings call
News Preview
BIRMINGHAM, Ala., Oct. 7, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept. 30, 2025, after the market closes on Wednesday, Oct. 29, 2025. The Company will host an investor conference call at 10 a.m. ET on Thursday, Oct. 30, 2025, to d...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
07.10.2025
ISIN: US60855R1005

Molina Healthcare Inc
MOH

LISTED

NYSE
MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purcha...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US6907321029

Owens & Minor Inc
OMI

LISTED

NYSE
PLATINUM EQUITY TO ACQUIRE PRODUCTS & HEALTHCARE SERVICES BUSINESS FROM OWENS & MINOR
News Preview
Standalone P&HS anticipated to benefit from Platinum's carve-out experience, sector expertise and commitment to growth Owens & Minor to retain a 5% equity stake in the business LOS ANGELES, Oct. 7, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US8051111016

Savara Inc
SVRA

LISTED

NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) bet...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US6907321029

Owens & Minor Inc
OMI

LISTED

NYSE
Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake
News Preview
Owens & Minor, Inc. (NYSE: OMI) today announced that it has entered into a definitive agreement for the sale of the Company’s Products & Healthcare Services (P&HS) segment to Platinum Equity. Over the last several years, Owens & Minor has been strategically moving towards expanding its leadership position in the very attractive hom...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US00404A1097

Acadia Healthcare Company Inc
ACHC

LISTED

NASDAQ
Acadia Healthcare Appoints Todd Young as Chief Financial Officer
News Preview
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia” or the “Company”) today announced the appointment of Todd Young as Chief Financial Officer, effective October 27, 2025. Tim Sides, who has been serving as the Company’s interim CFO since August 2025, will resume his role as Senior Vice President, Operations Finance. Young brings to Acadia...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US81684M1045

Semler Scientific Inc
SMLR

LISTED

NASDAQ
Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Oct. 7, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Semler Scientific Inc. ("Semler" or the "Company") (NASDAQ: SMLR). IF YOU AR...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US5165441032

Lantheus Holdings Inc
LNTH

LISTED

NASDAQ
Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
  BENSALEM, Pa., Oct. 7, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH)....
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: CA00288U1066

Abcellera Biologics Inc
ABCL

LISTED

NASDAQ
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
News Preview
AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences: Truist Securities BioPharma Symposium, November 6, 2025 Stifel Healthcare Conference, November 11-13, 2025 Jefferies Global Healthcare Conference, November 18-20, 2025 Piper Sandler 37th Annual Healthcare Conference, Decemb...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US67079U3068

Nutex Health Inc
NUTX

LISTED

NASDAQ
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX)....
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US23282W6057

Cytokinetics Inc
CYTK

LISTED

NASDAQ
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK)....
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US64125C1099

Neurocrine Biosciences Inc
NBIX

LISTED

NASDAQ
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2025 Financial Results
News Preview
Conference Call and Webcast Scheduled for Tuesday, October 28 SAN DIEGO, Oct. 7, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its third quarter 2025 financial results conference call and webcast for 1:30...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US4718711033

Jasper Therapeutics, Inc.
JSPR

LISTED

NASDAQ
Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ: JSPR)....
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US8051111016

Savara Inc
SVRA

LISTED

NASDAQ
Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US60855R1005

Molina Healthcare Inc
MOH

LISTED

NYSE
Rosen Law Firm Urges Molina Healthcare, Inc. (NYSE: MOH) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”). Molina is a health insurance company. For more information, sub...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US60855R1005

Molina Healthcare Inc
MOH

LISTED

NYSE
Deadline Alert: Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming December 2, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the “Class...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US60855R1005

Molina Healthcare Inc
MOH

LISTED

NYSE
MOH CLASS ACTION LAWSUIT: Molina Healthcare, Inc. Medical Costs Trigger Securities Fraud Class Action after Stock Plummets 16% -- Investors Urged to Contact BFA Law
News Preview
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Molina, you are encouraged to obtain additional information by visiting: https://...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US76152G1004

Reviva Pharmaceuticals Holdings, Inc.
RVPH

LISTED

NASDAQ
Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners
News Preview
CUPERTINO, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxmi...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US92511W1080

Verrica Pharmaceuticals Inc
VRCA

LISTED

NASDAQ
Verrica Pharmaceuticals to Present New Data on VP-315 from its Phase 2 Trial in Basal Cell Carcinoma (BCC) at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
News Preview
WEST CHESTER, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that it will be presenting both an oral presentation and a poster on VP-315, its oncolytic peptide fo...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US5588681057

Madrigal Pharmaceuticals Inc
MDGL

LISTED

NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on October 1, 2025 to 27 new non-executive employees as equity inducement...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: US4525253062

ImmuCell Corporation
ICCC

LISTED

NASDAQ
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
News Preview
PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited sales r...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: US60855R1005

Molina Healthcare Inc
MOH

LISTED

NYSE
MOLINA HEALTHCARE SHAREHOLDER ALERT By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Molina Healthcare, Inc. - MOH
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 2, 2025 to file lead plaintiff applications in a securities class action lawsuit against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH), if they purchased or otherwise acqui...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: JP3701000006

JCR Pharmaceuticals Co., Ltd.
45520

LISTED

XJPX
JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to Central Nervous System and Muscle with Novel Capsid Engineering Platform Technology
News Preview
JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today presented non-clinical data demonstrating the ability of its proprietary JUST-AAV capsid engineering platform to achieve efficient delivery of adeno-associated virus (AAV) gene therapy...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US91864C1071

Vaccitech plc
VACC

LISTED

NASDAQ
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ETNB, TRML, CORZ, BRNS on Behalf of Shareholders
News Preview
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...
Themefolio
Profiler
Peergroup
© Newsfile
07.10.2025
ISIN: US68764Y2072

OS Therapies, Inc
OSTX

LISTED

XASE
OS Therapies to Participate in Fall 2025 Conferences and Events
News Preview
Daytime Emmy Awards participation - 2 nomination for 'Shelter Me: Cancer Pioneers' Comparative Oncology documentary that features clinicians, veterinarians and human & canine patients who participated in OST-HER2 clinical trialsNew York, New York--(Newsfile Corp. - October 7, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "t...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: CH0432492467

Alcon AG
ALC

LISTED

NYSE
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
News Preview
CHARLOTTE, N.C., Oct. 7, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement outlining its opposition of the...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: FI4000087861

Herantis Pharma Oyj
HRTIS

LISTED

HEL
Herantis Pharma presents positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease
News Preview
Herantis Pharma announces positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: FR0010259150

Ipsen SA
IPN

LISTED

EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 40 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
07.10.2025
ISIN: US18507C1036

Clearpoint Neuro Inc
CLPT

LISTED

NASDAQ
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
News Preview
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced results from a Phase I-II clinical study at Skåne University Hospital in Lund, Sweden evaluat...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: DE000BAY0017

Bayer AG
BAYN

LISTED

XETR
Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest
News Preview
Bayer is proud to announce that Cornfed Farms, a fourth-generation farm operated by the Mohr family, has been designated as the first Bayer ForwardFarm site in the Midwest and the only ForwardFarm in the United States. This recognition places Cornfed Farms as one of 16 farms around the globe, highlighted by Bayer as committed to advancing regenera...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: FR0010259150

Ipsen SA
IPN

LISTED

EURONEXT
Ipsen - September 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
News Preview
Monthly information relative to the total number of voting rights and shares composing the share capital...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2025
ISIN: GB00BYMT0J19

LivaNova PLC
LIVN

LISTED

NASDAQ
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its participation in the International Surgical Sleep Society (ISSS) 2025 Annual Meeting in Indianapolis. The Company will present a five-year analysis of the THN-3 randomized control trial (RCT), which studied the use of its aura6000™ System for the treatmen...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: DE0005313704

Carl Zeiss Meditec AG
AFX

LISTED

XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025: NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: DE0005313704

Carl Zeiss Meditec AG
AFX

LISTED

XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025: NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US15102K1007

Celcuity Inc
CELC

LISTED

NASDAQ
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
News Preview
USA News Group News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 7, 2025 /CNW/ -- USA...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: DE0005313704

Carl Zeiss Meditec AG
AFX

LISTED

XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025: NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US98956P1021

Zimmer Biomet Holdings Inc
ZBH

LISTED

NYSE
Zimmer Biomet Completes Acquisition of Monogram Technologies
News Preview
Transaction creates the  broadest, most flexible portfolio of orthopedic robotics and navigation technologies, including pathway towards the first fully autonomous robotic technology for orthopedic procedures  WARSAW, Ind., Oct. 7, 2025 /PRNewswire/ -- Zimmer B...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US15102K1007

Celcuity Inc
CELC

LISTED

NASDAQ
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
News Preview
USA News Group News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US1266501006

CVS Health Corp
CVS

LISTED

NYSE
CVS Health opens new Workforce Innovation and Talent Center in Fort Worth
News Preview
In collaboration with Fort Worth Housing Solutions, the center offers no-cost training for Fort Worth's future health care workforce FORT WORTH, Texas, Oct. 7, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) is expanding access to health care careers with the launc...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US15102K1007

Celcuity Inc
CELC

LISTED

NASDAQ
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
News Preview
USA News Group News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 7, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: DE0005313704

Carl Zeiss Meditec AG
AFX

LISTED

XETR
ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization
News Preview
Showcasing at AAO 2025: NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
ISIN: DK0015998017

Bavarian Nordic A/S
BAVA

LISTED

CPH
Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population
News Preview
COPENHAGEN, Denmark, October 7, 2025 – Bavarian Nordic A/S (OMX: BAVA) today reported topline results from a clinical study of its MVA-BN® mpox/smallpox vaccine in children 2 to 11 years of age....
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US47973J1025

Joint Corp
JYNT

LISTED

NASDAQ
The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List
News Preview
SCOTTSDALE, Ariz., Oct. 7, 2025 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, has been recognized on the annual Franchise Times Top 400. The list ranks the largest franchised systems, based in the United States, accordin...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US17331Y1091

Citius Oncology, Inc.
CTOR

LISTED

NASDAQ
Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe
News Preview
Exclusive relationship through Named Patient Programs establishes footprint in Greece, Cyprus and additional Balkan countries CRANFORD, N.J., Oct. 7, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biop...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: CA01559R4008

Algernon Pharmaceuticals Inc.
AGN

LISTED

CSE
Catalyst MedTech Launches "Connect" Program to Expand Access to Advanced Imaging; Announces Initial Partnership with Algernon Pharmaceuticals
News Preview
PITTSBURGH, Oct. 7, 2025 /PRNewswire/ -- Catalyst MedTech today announced the launch of its new Connect program, an initiative that brings together collaborators seeking to advance patient care with the access required to make it possible. Connect leverages Catalyst's unique dual business structure—Equipment Solu...
Themefolio
Profiler
Peergroup
© Newsfile
07.10.2025
ISIN: CA09073K1084

Biomark Diagnostics Inc.
BUX

LISTED

CSE
BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial
News Preview
Extensive Validation of BioMark's Comprehensive Metabolic Panel in German 10,000-Participant HANSE Study, within the context of an international consortium supported under the EUREKA Network.Vancouver, British Columbia--(Newsfile Corp. - October 7, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leadin...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US2290503075

Cryoport Inc
CYRX

LISTED

NASDAQ
MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars
News Preview
Connected, Intelligent Condition Monitoring Assets that Safeguard Vital Life Science Materials Mark MVE's First Step in its Real-Time Integrated Systems Evolution NASHVILLE, Tenn., Oct. 7, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX), a global leader in su...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US48669G2049

Kazia Therapeutics Ltd
KZIA

LISTED

NASDAQ
Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program
News Preview
SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the "Agreement") with QIMR Berghofer for a first-in-class PD-L1 degrader program. The lead optimized compound, NDL2,...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ISIN: US03528H1095

Anixa Biosciences, Inc.
ANIX

LISTED

NASDAQ
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
News Preview
Final Clinical Visit Marks Major Milestone in First-in-Human Evaluation of Breast Cancer Vaccine Comprehensive Immune Response and Safety Data to Be Presented at the San Antonio Breast Cancer Symposium in December...
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2025 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Friday, 14.11.2025, Calendar Week 46, 318th day of the year, 47 days remaining until EoY.